SKCCC at Johns Hopkins

Baltimore, Maryland 21287

1 studies enrolling now · 7 studies all time

What they study most

Ataxia-Telangiectasia (A-T), Castration Resistant Metastatic Prostate Cancer, Complete Response, Epithelial Ovarian Cancer, FIGO Stage III-IV, Fallopian Tube Cancer, Gastric Cancer, Gastroesophageal Cancer, Metastatic Esophageal Cancer, Newly Diagnosed, Partial Response, Primary Peritoneal

Studies at this site

• Image-guided Focal Brachytherapy Utilizing Combined 18F-DCFPyl PET/CT — Recruiting now
• Assessing Induction of Double Strand Breaks With Androgen Receptor Partial Agonist in Patients on Androgen Suppression — Completed
• A Study in Ovarian Cancer Patients Evaluating Rucaparib and Nivolumab as Maintenance Treatment Following Response to Front-Line Platinum-Based Chemotherapy — Running, not enrolling
• Olaratumab (LY3012207) Patient Access for Soft Tissue Sarcoma — APPROVED_FOR_MARKETING
• Testosterone Revival Abolishes Negative Symptoms, Fosters Objective Response and Modulates Enzalutamide Resistance — Completed
• Cell-Based Approaches For Modeling and Treating Ataxia-Telangiectasia — Stopped early
• Phase II Study Using CHFR Methylation Status in Patients With Metastatic Esophageal, Gastroesophageal, Gastric Cancer. — Completed